Regulatory-ready foundations for translational success
Successful translation requires more than strong science; it requires infrastructure designed with regulatory expectations in mind. MN-BRIDGE provides an agile, plug-and-play research infrastructure aligned with CBER guidelines and best practices across regenerative medicine applications.

We support investigators by standardizing study design, documentation, and reporting, enabling smoother transitions from preclinical research to IND-enabling studies and regulatory submissions. This shared infrastructure minimizes delays, increases confidence among regulators and investors, and enhances reproducibility across projects.

What we provide:

• CBER-aligned study protocols tailored for RM applications
• IACUC and IBC protocol expertise in major RM categories
• GLP-ready reporting templates and standardized documentation
• Integrated digital pathology and data management workflows
• Pre-IND / Pre-IDE consultation and study planning support

This infrastructure allows investigators to focus on innovation while ensuring regulatory readiness from the outset.